Indications for Digital Monitoring of Patients With Multiple Nevi: Recommendations from the International Dermoscopy Society.
dermatoscopy
dermoscopy
digital monitoring
multiple nevi
total body photography
Journal
Dermatology practical & conceptual
ISSN: 2160-9381
Titre abrégé: Dermatol Pract Concept
Pays: Austria
ID NLM: 101585990
Informations de publication
Date de publication:
Nov 2022
Nov 2022
Historique:
accepted:
13
01
2022
entrez:
19
12
2022
pubmed:
20
12
2022
medline:
20
12
2022
Statut:
epublish
Résumé
In patients with multiple nevi, sequential imaging using total body skin photography (TBSP) coupled with digital dermoscopy (DD) documentation reduces unnecessary excisions and improves the early detection of melanoma. Correct patient selection is essential for optimizing the efficacy of this diagnostic approach. The purpose of the study was to identify, via expert consensus, the best indications for TBSP and DD follow-up. This study was performed on behalf of the International Dermoscopy Society (IDS). We attained consensus by using an e-Delphi methodology. The panel of participants included international experts in dermoscopy. In each Delphi round, experts were asked to select from a list of indications for TBSP and DD. Expert consensus was attained after 3 rounds of Delphi. Participants considered a total nevus count of 60 or more nevi or the presence of a CDKN2A mutation sufficient to refer the patient for digital monitoring. Patients with more than 40 nevi were only considered an indication in case of personal history of melanoma or red hair and/or a MC1R mutation or history of organ transplantation. Our recommendations support clinicians in choosing appropriate follow-up regimens for patients with multiple nevi and in applying the time-consuming procedure of sequential imaging more efficiently. Further studies and real-life data are needed to confirm the usefulness of this list of indications in clinical practice.
Identifiants
pubmed: 36534527
doi: 10.5826/dpc.1204a182
pii: dp1204a182
pmc: PMC9681223
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e2022182Subventions
Organisme : NCI NIH HHS
ID : P30 CA008748
Pays : United States
Informations de copyright
©2022 Russo et al.
Déclaration de conflit d'intérêts
Competing interests: None.
Références
Eur J Cancer. 2005 Jan;41(1):45-60
pubmed: 15617990
JAMA Dermatol. 2021 May 1;157(5):521-530
pubmed: 33729464
JAMA Dermatol. 2015 Feb;151(2):178-86
pubmed: 25389712
Br J Dermatol. 2019 Nov;181(5):1009-1016
pubmed: 30820946
JAMA Dermatol. 2016 Mar;152(3):291-8
pubmed: 26536613
Plast Reconstr Surg. 2011 Jul;128(1):305-310
pubmed: 21701348
J Med Genet. 2016 Jan;53(1):1-14
pubmed: 26337759
Curr Dermatol Rep. 2013 Mar 1;2(1):24-34
pubmed: 23580930
J Am Acad Dermatol. 2020 Feb;82(2):398-406
pubmed: 31499156
J Natl Cancer Inst. 2002 Jun 19;94(12):894-903
pubmed: 12072543
Cell Mol Life Sci. 2015 Apr;72(7):1249-60
pubmed: 25433395
Eur J Cancer. 2005 Jan;41(1):28-44
pubmed: 15617989
Int J Cancer. 2008 Jun 15;122(12):2753-60
pubmed: 18366057
J Natl Cancer Inst. 2005 Oct 19;97(20):1507-15
pubmed: 16234564
Cancer Epidemiol Biomarkers Prev. 2010 Jul;19(7):1686-95
pubmed: 20570907
Arch Dermatol. 2011 Jul;147(7):790-6
pubmed: 21768478
JAMA Dermatol. 2014 Aug;150(8):819-27
pubmed: 24964862
Int J Epidemiol. 2006 Dec;35(6):1514-21
pubmed: 16943234
Br J Dermatol. 2008 Sep;159(3):669-76
pubmed: 18616769
Eur J Med Chem. 2020 Oct 15;204:112531
pubmed: 32712436
Arch Dermatol. 2010 Mar;146(3):257-64
pubmed: 20231495
J Invest Dermatol. 2000 Jan;114(1):28-33
pubmed: 10620111
Eur J Cancer. 2005 Sep;41(14):2040-59
pubmed: 16125929
Eur J Hum Genet. 2011 Apr;19(4):472-8
pubmed: 21150883
Br J Dermatol. 2015 Jan;172(1):33-47
pubmed: 25204572
J Eur Acad Dermatol Venereol. 2021 Feb;35(2):403-410
pubmed: 32455486
J Eur Acad Dermatol Venereol. 2017 Jun;31(6):972-977
pubmed: 27896853
JAMA Dermatol. 2015 Jun;151(6):607-15
pubmed: 25671687
J Adv Nurs. 2000 Oct;32(4):1008-15
pubmed: 11095242
Dermatology. 2015;230(4):340-6
pubmed: 25675954
J Clin Oncol. 2017 Jan;35(1):63-71
pubmed: 28034073
Int J Cancer. 2011 Oct 1;129(7):1730-40
pubmed: 21128237
JAMA. 2011 Nov 2;306(17):1891-901
pubmed: 22045767
Clin Lab Med. 2017 Sep;37(3):473-484
pubmed: 28802496
J Eur Acad Dermatol Venereol. 2017 Feb;31(2):247-251
pubmed: 27422807
G Ital Dermatol Venereol. 2017 Jun;152(3):213-223
pubmed: 28121084